As the coronavirus vaccine rolls out across the country, an infectious disease expert answers questions about its safety and when it’s likely to be available to the general public.
Human organoids, tiny organ-like structures grown in the laboratory, can be used to identify potential COVID-19 drugs in an automated, high-throughput fashion.
T-cells taken from the blood of people who recovered from a COVID-19 infection can be successfully multiplied in the lab and maintain the ability to effectively target proteins that are key to the virus’s function.
When a patient is hospitalized with COVID-19, signs of damage to the right side of the heart may indicate a greater risk of death, according to a study from investigators at Weill Cornell Medicine and NewYork-Presbyterian.
It began as a spark of interest in remote healthcare, gained momentum four years ago with the introduction of a suite of digital health services, then exploded when COVID-19 strained the system, making hospital and doctor visits anything but routine. Today, telemedicine—as a panel of experts at an Oct. 1 Weill Cornell Medicine webinar agreed—is no longer a futuristic idea but an immediate and vital tool for doctors and patients alike.
The amount of SARS-CoV-2 virus, or “viral load,” in cancer patients and in the general inpatient population upon hospital admission may predict their risk of dying of the infection, according to a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
A study by investigators at Weill Cornell Medicine and NewYork-Presbyterian aims to answer one of COVID-19’s biggest mysteries: why do some people become severely ill, while others have no symptoms?
Weill Cornell Medicine has awarded eight grants of $100,000 each to faculty for a variety of research projects on COVID-19, funded by the institution’s Board of Overseers and additional donors. The grants will support studies aimed at understanding fundamental aspects of the disease, the body’s immune response and social determinants of health that affect COVID-19 outcomes.
Dr. Kristen Marks, an associate professor of medicine in the Division of Infectious Diseases at Weill Cornell Medicine and associate attending physician at the medical center, leads the team conducting Moderna Therapeutics’s phase 3 COVID-19 vaccine trial at NewYork-Presbyterian/Weill Cornell Medical Center—one of dozens of medical centers around the U.S. where this still-experimental vaccine will be tested.
My wife thinks she got me sick, and I think I got her sick. She was serving on a grand jury—in a room with dozens of people who had sniffles and coughs—and one afternoon she called me and said she’d been sent home with a fever and didn’t feel well.
Home health care workers faced increased risks to their physical, mental and financial well-being while providing essential care to patients during the COVID-19 pandemic, according to researchers at Weill Cornell Medicine, Cornell Tech and Cornell University.
Until very recently, face masks were seldom seen in the United States outside of doctors’ offices, operating rooms and sometimes beauty salons. Now, because of the COVID-19 pandemic, the Centers for Disease Control and Prevention recommends wearing a mask or face covering in public, particularly in situations where social distancing is not possible.
The study of human pluripotent stem cells, which can develop into any cell type in the body, is providing Weill Cornell Medicine and NewYork-Presbyterian investigators with new insights into the virus that causes COVID-19 and how it may infect organs such as the pancreas and liver.
A code discovered in DNA packaging proteins enables the rapid expression of genes needed to fight immediate threats, a finding that may pave the way for new treatments for cancer and inflammatory diseases.
Medical students at Weill Cornell Medicine-Qatar (WCM-Q) have answered a call from the Ministry of Public Health (MOPH) for volunteers to help tackle the COVID-19 pandemic.
With cases of COVID-19 spiking in many areas of the United States, and a greater resurgence expected in the fall, whether and how to reopen schools is the subject of strong national interest.
Researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have published guidance on how physicians working on the front lines of the COVID-19 pandemic can compassionately inform family members of the painful news that their loved one has died.
Hematology and oncology specialist Dr. Jeffrey Laurence answers questions about the connection between blood clotting and other symptoms of severe COVID-19.
COVID-19 patients have a higher risk of stroke than patients with influenza, according to a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.
